Blood Transfusion Market By Type (Y-type, Straight, Other) , By Application (Child, Adult) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Blood Transfusion Market Expected to Garner $12.3 Billion by 2033, Growing at a CAGR of 6.2%
The global blood transfusion market is expected to grow primarily due to the rising demand for blood products due to the prevalence of chronic diseases and the rising number of surgical procedures & trauma cases. The Asia-Pacific region is predicted to witness profitable growth by 2033.
As per the report published by Research Dive, the global blood transfusion market was valued at $7.0 billion in 2023 and is expected to register a revenue of $12.3 billion by 2033 at a CAGR of 6.2% during the forecast period 2024-2033.
Dynamics of the Market
The growing prevalence of anemia, rising geriatric population requiring transfusions for age-related conditions, and the increasing initiatives aimed at promoting donation campaigns across the globe are expected to make the blood transfusion market a highly profitable one in the forecast period. Besides, the growing demand for blood products due to the prevalence of chronic diseases, trauma cases, and surgical procedures are predicted to further boost the market growth.
However, according to market analysts, the risk of allergic reactions and regulatory compliance challenges associated with blood transfusion practices might restrain the growth of the market.
Integration of advanced omics technologies and technological innovations in blood storage & transfusion equipment present significant opportunities for blood transfusion market growth. Moreover, efforts among healthcare institutions, blood banks, and regulatory bodies to improve the safety & efficiency of blood transfusions will help the market growth in the coming years.
Key Players of the Market
The major players of the blood transfusion market include F. Hoffmann-La Roche AG, BIO KIT (Werfen), Abbott, Ortho Clinical Diagnostics, Immucor Inc., Bio-Rad Laboratories, BAG Healthcare GmbH, Quotient Limited, Danaher, and DiaSorin S.P.A.
What the Report Covers
In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).
Key Market Segments
By Type
Y-type
Straight
Other
By Application
Child
Adult
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
UAE
Rest of LAMEA
Key Market Players
Abbott
F. HOFFMANN-LA ROCHE AG
Ortho Clinical Diagnostics
BIO KIT (Werfen)
Bio-Rad Laboratories
Immucor, Inc
BAG Health Care GmbH
Danaher
DiaSorin S.p.A.
QUOTIENT LIMITED
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: BLOOD TRANSFUSION MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Y-type
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Straight
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Other
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: BLOOD TRANSFUSION MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Child
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Adult
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: BLOOD TRANSFUSION MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Type
- 6.2.3. Market Size and Forecast, By Application
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Blood Transfusion Market
- 6.2.5.1. Market Size and Forecast, By Type
- 6.2.5.2. Market Size and Forecast, By Application
- 6.2.6. Canada Blood Transfusion Market
- 6.2.6.1. Market Size and Forecast, By Type
- 6.2.6.2. Market Size and Forecast, By Application
- 6.2.7. Mexico Blood Transfusion Market
- 6.2.7.1. Market Size and Forecast, By Type
- 6.2.7.2. Market Size and Forecast, By Application
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Type
- 6.3.3. Market Size and Forecast, By Application
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. France Blood Transfusion Market
- 6.3.5.1. Market Size and Forecast, By Type
- 6.3.5.2. Market Size and Forecast, By Application
- 6.3.6. Germany Blood Transfusion Market
- 6.3.6.1. Market Size and Forecast, By Type
- 6.3.6.2. Market Size and Forecast, By Application
- 6.3.7. Italy Blood Transfusion Market
- 6.3.7.1. Market Size and Forecast, By Type
- 6.3.7.2. Market Size and Forecast, By Application
- 6.3.8. Spain Blood Transfusion Market
- 6.3.8.1. Market Size and Forecast, By Type
- 6.3.8.2. Market Size and Forecast, By Application
- 6.3.9. UK Blood Transfusion Market
- 6.3.9.1. Market Size and Forecast, By Type
- 6.3.9.2. Market Size and Forecast, By Application
- 6.3.10. Rest Of Europe Blood Transfusion Market
- 6.3.10.1. Market Size and Forecast, By Type
- 6.3.10.2. Market Size and Forecast, By Application
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Type
- 6.4.3. Market Size and Forecast, By Application
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. China Blood Transfusion Market
- 6.4.5.1. Market Size and Forecast, By Type
- 6.4.5.2. Market Size and Forecast, By Application
- 6.4.6. Japan Blood Transfusion Market
- 6.4.6.1. Market Size and Forecast, By Type
- 6.4.6.2. Market Size and Forecast, By Application
- 6.4.7. India Blood Transfusion Market
- 6.4.7.1. Market Size and Forecast, By Type
- 6.4.7.2. Market Size and Forecast, By Application
- 6.4.8. South Korea Blood Transfusion Market
- 6.4.8.1. Market Size and Forecast, By Type
- 6.4.8.2. Market Size and Forecast, By Application
- 6.4.9. Australia Blood Transfusion Market
- 6.4.9.1. Market Size and Forecast, By Type
- 6.4.9.2. Market Size and Forecast, By Application
- 6.4.10. Rest of Asia-Pacific Blood Transfusion Market
- 6.4.10.1. Market Size and Forecast, By Type
- 6.4.10.2. Market Size and Forecast, By Application
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Type
- 6.5.3. Market Size and Forecast, By Application
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Blood Transfusion Market
- 6.5.5.1. Market Size and Forecast, By Type
- 6.5.5.2. Market Size and Forecast, By Application
- 6.5.6. South Africa Blood Transfusion Market
- 6.5.6.1. Market Size and Forecast, By Type
- 6.5.6.2. Market Size and Forecast, By Application
- 6.5.7. Saudi Arabia Blood Transfusion Market
- 6.5.7.1. Market Size and Forecast, By Type
- 6.5.7.2. Market Size and Forecast, By Application
- 6.5.8. UAE Blood Transfusion Market
- 6.5.8.1. Market Size and Forecast, By Type
- 6.5.8.2. Market Size and Forecast, By Application
- 6.5.9. Rest of LAMEA Blood Transfusion Market
- 6.5.9.1. Market Size and Forecast, By Type
- 6.5.9.2. Market Size and Forecast, By Application
- CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping Of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
- CHAPTER 8: COMPANY PROFILES
- 8.1. Abbott
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. F. HOFFMANN-LA ROCHE AG
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. Ortho Clinical Diagnostics
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. BIO KIT (Werfen)
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Bio-Rad Laboratories
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Immucor, Inc
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. BAG Health Care GmbH
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Danaher
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. DiaSorin S.p.A.
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. QUOTIENT LIMITED
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 2. BLOOD TRANSFUSION MARKET FOR Y-TYPE, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 3. BLOOD TRANSFUSION MARKET FOR STRAIGHT, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 4. BLOOD TRANSFUSION MARKET FOR OTHER, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 5. GLOBAL BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 6. BLOOD TRANSFUSION MARKET FOR CHILD, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 7. BLOOD TRANSFUSION MARKET FOR ADULT, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 8. BLOOD TRANSFUSION MARKET, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 9. NORTH AMERICA BLOOD TRANSFUSION MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 10. NORTH AMERICA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 11. NORTH AMERICA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 12. U.S. BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 13. U.S. BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 14. CANADA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 15. CANADA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 16. MEXICO BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 17. MEXICO BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 18. EUROPE BLOOD TRANSFUSION MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 19. EUROPE BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 20. EUROPE BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 21. FRANCE BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 22. FRANCE BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 23. GERMANY BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 24. GERMANY BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 25. ITALY BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 26. ITALY BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 27. SPAIN BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 28. SPAIN BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 29. UK BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 30. UK BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 31. REST OF EUROPE BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 32. REST OF EUROPE BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 33. ASIA-PACIFIC BLOOD TRANSFUSION MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 34. ASIA-PACIFIC BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 35. ASIA-PACIFIC BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 36. CHINA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 37. CHINA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 38. JAPAN BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 39. JAPAN BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 40. INDIA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 41. INDIA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 42. SOUTH KOREA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 43. SOUTH KOREA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 44. AUSTRALIA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 45. AUSTRALIA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 46. REST OF ASIA-PACIFIC BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 47. REST OF ASIA-PACIFIC BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 48. LAMEA BLOOD TRANSFUSION MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 49. LAMEA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 50. LAMEA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 51. BRAZIL BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 52. BRAZIL BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 53. SOUTH AFRICA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 54. SOUTH AFRICA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 55. SAUDI ARABIA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 56. SAUDI ARABIA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 57. UAE BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 58. UAE BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 59. REST OF LAMEA BLOOD TRANSFUSION MARKET, BY TYPE, 2024 - 2033 ($MILLION)
- TABLE 60. REST OF LAMEA BLOOD TRANSFUSION MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 61. ABBOTT: KEY EXECUTIVES
- TABLE 62. ABBOTT: COMPANY SNAPSHOT
- TABLE 63. ABBOTT: OPERATING SEGMENTS
- TABLE 64. ABBOTT: PRODUCT PORTFOLIO
- TABLE 65. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 66. F. HOFFMANN-LA ROCHE AG: KEY EXECUTIVES
- TABLE 67. F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
- TABLE 68. F. HOFFMANN-LA ROCHE AG: OPERATING SEGMENTS
- TABLE 69. F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
- TABLE 70. F. HOFFMANN-LA ROCHE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 71. ORTHO CLINICAL DIAGNOSTICS: KEY EXECUTIVES
- TABLE 72. ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT
- TABLE 73. ORTHO CLINICAL DIAGNOSTICS: OPERATING SEGMENTS
- TABLE 74. ORTHO CLINICAL DIAGNOSTICS: PRODUCT PORTFOLIO
- TABLE 75. ORTHO CLINICAL DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 76. BIO KIT (WERFEN) : KEY EXECUTIVES
- TABLE 77. BIO KIT (WERFEN) : COMPANY SNAPSHOT
- TABLE 78. BIO KIT (WERFEN) : OPERATING SEGMENTS
- TABLE 79. BIO KIT (WERFEN) : PRODUCT PORTFOLIO
- TABLE 80. BIO KIT (WERFEN) : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 81. BIO-RAD LABORATORIES: KEY EXECUTIVES
- TABLE 82. BIO-RAD LABORATORIES: COMPANY SNAPSHOT
- TABLE 83. BIO-RAD LABORATORIES: OPERATING SEGMENTS
- TABLE 84. BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
- TABLE 85. BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 86. IMMUCOR, INC: KEY EXECUTIVES
- TABLE 87. IMMUCOR, INC: COMPANY SNAPSHOT
- TABLE 88. IMMUCOR, INC: OPERATING SEGMENTS
- TABLE 89. IMMUCOR, INC: PRODUCT PORTFOLIO
- TABLE 90. IMMUCOR, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 91. BAG HEALTH CARE GMBH: KEY EXECUTIVES
- TABLE 92. BAG HEALTH CARE GMBH: COMPANY SNAPSHOT
- TABLE 93. BAG HEALTH CARE GMBH: OPERATING SEGMENTS
- TABLE 94. BAG HEALTH CARE GMBH: PRODUCT PORTFOLIO
- TABLE 95. BAG HEALTH CARE GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 96. DANAHER: KEY EXECUTIVES
- TABLE 97. DANAHER: COMPANY SNAPSHOT
- TABLE 98. DANAHER: OPERATING SEGMENTS
- TABLE 99. DANAHER: PRODUCT PORTFOLIO
- TABLE 100. DANAHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 101. DIASORIN S.P.A.: KEY EXECUTIVES
- TABLE 102. DIASORIN S.P.A.: COMPANY SNAPSHOT
- TABLE 103. DIASORIN S.P.A.: OPERATING SEGMENTS
- TABLE 104. DIASORIN S.P.A.: PRODUCT PORTFOLIO
- TABLE 105. DIASORIN S.P.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 106. QUOTIENT LIMITED: KEY EXECUTIVES
- TABLE 107. QUOTIENT LIMITED: COMPANY SNAPSHOT
- TABLE 108. QUOTIENT LIMITED: OPERATING SEGMENTS
- TABLE 109. QUOTIENT LIMITED: PRODUCT PORTFOLIO
- TABLE 110. QUOTIENT LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL BLOOD TRANSFUSION MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF BLOOD TRANSFUSION MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN BLOOD TRANSFUSION MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBLOOD TRANSFUSION MARKET
- FIGURE 10. GLOBAL BLOOD TRANSFUSION MARKET SEGMENTATION, BY TYPE
- FIGURE 11. BLOOD TRANSFUSION MARKET FOR Y-TYPE, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 12. BLOOD TRANSFUSION MARKET FOR STRAIGHT, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 13. BLOOD TRANSFUSION MARKET FOR OTHER, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 14. GLOBAL BLOOD TRANSFUSION MARKET SEGMENTATION, BY APPLICATION
- FIGURE 15. BLOOD TRANSFUSION MARKET FOR CHILD, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 16. BLOOD TRANSFUSION MARKET FOR ADULT, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 21. COMPETITIVE DASHBOARD
- FIGURE 22. COMPETITIVE HEATMAP: BLOOD TRANSFUSION MARKET
- FIGURE 23. TOP PLAYER POSITIONING, 2023
- FIGURE 24. ABBOTT: NET SALES, 2021-2023 ($MILLION)
- FIGURE 25. ABBOTT: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 26. ABBOTT: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 27. F. HOFFMANN-LA ROCHE AG: NET SALES, 2021-2023 ($MILLION)
- FIGURE 28. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 29. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 30. ORTHO CLINICAL DIAGNOSTICS: NET SALES, 2021-2023 ($MILLION)
- FIGURE 31. ORTHO CLINICAL DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. ORTHO CLINICAL DIAGNOSTICS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. BIO KIT (WERFEN) : NET SALES, 2021-2023 ($MILLION)
- FIGURE 34. BIO KIT (WERFEN) : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. BIO KIT (WERFEN) : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. BIO-RAD LABORATORIES: NET SALES, 2021-2023 ($MILLION)
- FIGURE 37. BIO-RAD LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. IMMUCOR, INC: NET SALES, 2021-2023 ($MILLION)
- FIGURE 40. IMMUCOR, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. IMMUCOR, INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. BAG HEALTH CARE GMBH: NET SALES, 2021-2023 ($MILLION)
- FIGURE 43. BAG HEALTH CARE GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. BAG HEALTH CARE GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. DANAHER: NET SALES, 2021-2023 ($MILLION)
- FIGURE 46. DANAHER: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. DANAHER: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. DIASORIN S.P.A.: NET SALES, 2021-2023 ($MILLION)
- FIGURE 49. DIASORIN S.P.A.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. DIASORIN S.P.A.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. QUOTIENT LIMITED: NET SALES, 2021-2023 ($MILLION)
- FIGURE 52. QUOTIENT LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. QUOTIENT LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook